Effects of an extended MRI approval of an implantable spinal cord stimulation device on compliance with manufacturer's recommendations.

Objective: The current approval for all available spinal cord stimulation (SCS) devices set several limitations for magnetic resonance imaging (MRI). As a result, most of the necessary examinations are not possible within the scope of the restrictive approvals and, if legally permitted, must be carr...

Descripción completa

Detalles Bibliográficos
Publicado en:Pain Practice Vol. 25; no. 4; pp. 1 - 9
Autores principales: Reining, Marco, Winkler, Dirk, Kirchhof, Klaus, Boettcher, Joachim, Kretzschmar, Michael
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Apr2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184297892&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 184297892
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15307085
        HYN
      jtl: Pain Practice
      issn: 15307085
      maglogo: Y
    pubinfo:
      dt: Apr2025
      vid: 25
      iid: 4
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        184297892
        184297892
        184297892
        10.1111/papr.70022
        184297892
      ppf: 1
      ppct: 8
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Effects of an extended MRI approval of an implantable spinal cord stimulation device on compliance with manufacturer's recommendations.
      aug:
        au:
          Reining, Marco
          Winkler, Dirk
          Kirchhof, Klaus
          Boettcher, Joachim
          Kretzschmar, Michael
        affil: Department of Pain Medicine and Palliative Care, SRH Wald‐Klinikum Gera GmbH, Gera, Germany
      sug:
        subj:
          Spinal Cord Stimulation Equipment and Supplies
          Device Approval
          Magnetic Resonance Imaging Methods
          Professional Compliance Evaluation
          Spinal Cord Stimulation Methods
          Electrodes, Implanted
          Patient Safety
          Product Evaluation
          Human
          Funding Source
          Male
          Female
          Middle Age
          Aged
          Aged, 80 and Over
          Retrospective Design
          Record Review
          Descriptive Statistics
          Data Analysis Software
          Chi Square Test
          Time Factors
          Middle Aged: 45-64 years
          Aged: 65+ years
          Aged, 80 & over
          Male
          Female
      ab: Objective: The current approval for all available spinal cord stimulation (SCS) devices set several limitations for magnetic resonance imaging (MRI). As a result, most of the necessary examinations are not possible within the scope of the restrictive approvals and, if legally permitted, must be carried out off‐label. This retrospective subgroup analysis investigates if the currently extended MRI approval of one specific device allows more MRI scans to be conducted within the manufacturer's recommendations. Materials and Methods: Technical MRI data (saved in the DICOM headers) and medical treatment data for all MRI examinations on patients with Proclaim® implantable pulse generators (IPG; Proclaim® spinal cord stimulation systems, Abbott Laboratories, Plano, TX, USA) were examined. Due to a major change in our standard operating procedures for MRI scans in 2019, the two time periods (before and after 2019) were separately analyzed. Results: We identified 62 MRI scans with the IPG. The entire implanted system was approved for MRI examinations in just over 50% of the cases, regardless of old and new approval. Options for lead placement were expanded in the new approval; however, this did not significantly improve the number of MR conditional devices. By contrast, for a higher specific absorption rate, significantly more scans within the recommendations are possible in Period 2 (p = 0.011). However, the number of possible scans did not reach statistical significance in Period 1 (p = 0.078). No device‐related adverse events were noted. Conclusion: The new MRI approval is suitable for performing more scans within the manufacturer's specifications. Cervical leads remain problematic because longer leads are required, and the lower impedances inhibit the MRI mode.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N